The DOI matches its Crossref record, with a small difference in title or year; 121 of the 122 references it cites were found in a registry or an index.
Exercise and Type 2 Diabetes
Abstract
This pronouncement was written for the American College of Sports Medicine by: Ann Albright, Ph.D., R.D. (Chairperson); Marion Franz, M.S., R.D., C.D.E.; Guyton Hornsby, Ph.D., C.D.E.; Andrea Kriska, Ph.D., FACSM; David Marrero, Ph.D.; Irma Ullrich, M.D.; and Larry S. Verity, Ph.D., FACSM. SUMMARY Physical activity, including appropriate endurance and resistance training, is a major therapeutic modality for type 2 diabetes. Unfortunately, too often physical activity is an underutilized therapy. Favorable changes in glucose tolerance and insulin sensitivity usually deteriorate within 72 h of the last exercise session; consequently, regular physical activity is imperative to sustain glucose-lowering effects and improved insulin sensitivity. Individuals with type 2 diabetes should strive to achieve a minimum cumulative total of 1000 kcal·wk−1 from physical activities. Those with type 2 diabetes generally have a lower level of fitness (V̇O2max) than nondiabetic individuals, and therefore exercise intensity should be at a comfortable level (RPE 10–12) in the initial periods of training and should progress cautiously as tolerance for activity improves. Resistance training has the potential to improve muscle strength and endurance, enhance flexibility and body composition, decrease risk factors for cardiovascular disease, and result in improved glucose tolerance and insulin sensitivity. Modifications to exercise type and/or intensity may be necessary for those who have complications of diabetes. Individuals with type 2 diabetes may develop autonomic neuropathy, which affects the heart rate response to exercise, and as a result, ratings of perceived exertion rather than heart rate may need to be used for moderating intensity of physical activity. Although walking may be the most convenient low-impact mode, some persons, because of peripheral neuropathy and/or foot problems, may need to do non-weight-bearing activities. Outcome expectations may contribute significantly to motivation to begin and maintain an exercise program. Interventions designed to encourage adoption of an exercise regimen must be responsive to the individual’s current stage of readiness and focus efforts on moving the individual through the various “stages of change.” INTRODUCTION Diabetes is one of the leading causes of death and disability in the United States with type 2 diabetes accounting for 90–95% of all diabetic cases (77). Based on national data, there are about 10.3 million diagnosed cases of diabetes in the United States with an estimated 5.4 million additional undiagnosed cases in the general population (40). Unfortunately, the diagnosis of type 2 diabetes is often delayed for years after the onset of the disease. A large portion of the burden of the disease falls upon the minority populations of the U.S., demonstrated by the fact that the prevalence rates of diabetes are higher among Native Americans, African Americans, Hispanic Americans, and Asian and Pacific Island Americans when compared with non-Hispanic whites (99). The long-term complications associated with type 2 diabetes are both microvascular and macrovascular in nature and include the following: retinopathy, peripheral and autonomic neuropathy, nephropathy, peripheral vascular disease, atherosclerotic cardiovascular and cerebrovascular disease, hypertension, and susceptibility to infections and periodontal disease (for an extensive description of the complications associated with diabetes, the reader is referred to Diabetes in America, 1995; 80,81). The diagnosis and classification of diabetes have been revised by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (59). The new classification system emphasizes etiology and pathogenesis rather than modalities of treatment. Diabetes is divided into four major categories depending on etiology: type 1, type 2, gestational, and type diabetes, the is by which to insulin 2 diabetes is by of insulin resistance and insulin diabetes is as of glucose with onset The diabetes to and (59). for diabetes have been revised and are than the The new the prevalence of microvascular complications for diabetes. of must be for the diagnosis of a glucose of diabetes as and a glucose of and glucose an glucose tolerance of there is should be on a (59). and factors have been in the etiology of type 2 diabetes. is a for type of diabetes the are (59). the risk for the disease are minority and lower with type 2 diabetes factors that are in the of type 2 diabetes are physical and and 2 diabetes is a disease in which often insulin with The of type 2 diabetes to in both insulin and resistance is by of glucose as in the and the level muscle glucose may be from to and are is an in and may a is a with by as a that of as may be an in the by which are into the in insulin have been to be in insulin A in may and be in nondiabetic of with type 2 diabetes in insulin may be through factors as and may contribute to insulin resistance of m
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activities that greatly increase intraocular pressure, such as high-intensity aerobic or resistance training (with large increases in systolic BP) and head-down activities, are not advised with uncontrolled proliferative disease, nor are jumping or jarring activities, all of which increase hemorrhage risk ( 1 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [1]
Citations
Cites
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Physical Fitness and All-Cause Mortality: A Prospective Study of Healthy Men and Women
Blair, S. N. (1989) · JAMA · doi:10.1001/jama.1989.03430170057028 · Cited by 2,658
Self-Efficacy and the Stages of Exercise Behavior Change
Marcus, B. H., Selby, V. C., Niaura, R. S., & Rossi, J. S. (1992) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.1992.10607557 · Cited by 1,860
Physical activity and reduced occurrence of non–insulin-dependent diabetes mellitus
Helmrich, S. P., Ragland, D. R., Leung, R. W., & Paffenbarger, R. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107183250302 · Cited by 1,634
The Role of Self-Efficacy in Achieving Health Behavior Change
Strecher, V. J., McEvoy DeVellis, B., Becker, M. H., & Rosenstock, I. M. (1986) · Health Education Quarterly · doi:10.1177/109019818601300108 · Cited by 1,617
Physical activity and incidence of non-insulin-dependent diabetes mellitus in women
Manson, J. E., Stampfer, M. J., Colditz, G. A., Willett, W. C., Rosner, B., Hennekens, C. H., Speizer, F. E., Rimm, E. B., & Krolewski, A. S. (1991) · The Lancet · doi:10.1016/0140-6736(91)90664-b · Cited by 1,164
A descriptive study of individuals successful at long-term maintenance of substantial weight loss
Klem, M., Wing, R., McGuire, M., Seagle, H., & Hill, J. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.2.239 · Cited by 1,060
Ohlson, L. O., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,020
The metabolically obese, normal-weight individual revisited.
Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.699 · Cited by 893
A Prospective Study of Exercise and Incidence of Diabetes Among US Male Physicians
Manson, J. E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490010065031 · Cited by 778
Research works printed but not linked: 63
- Ajzen, 1980, Englewood Cliffs, NJ, Prentice
- 1993, Med Sci Sports Exerc, 25, i???x,
- 1999, Diabetes Care, 22, S24???S31,
- 1993, Diabetes Care, 16, 72???78,
- 1998, Diabetes Care, 21, 310???314,
- 1999, Diabetes Care, 22, S49???S53,
- 1989, Diabetes Care, 12, 573???79,
- 1995, Circulation, 91, 580???615,
- Ballor, 1996, Metabolism, 45, 179???183,
- Barnard, 1982, Diabetes Care, 5, 370???374,
- Barnard, 1992, J Cardiopulm Rehabil, 12, 194???201,
- Berntorp, 1986, Diabetes Res, 3, 231???236,
- Bj??rntorp, 1988, Diabetes Metab Rev, 4, 615???622,
- Bj??rntorp, 1991, Diabetes Care, 14, 1132???1143,
- Bj??rntorp, 1990, Arteriosclerosis, 10, 493???496,
- Bj??rntorp, 1992, Int J Obes Suppl, 16, 519???527,
- Bourn, 1995, Diabetes Care, 17, 1311???1319,
- Cederholm, 1985, Acta Med Scand, 217, 373???378,
- 1993, Sports Med Bull, 28, 7,
- 1999, Diabetes Care, 22, 623???634,
- Dowse, 1991, Diabetes Care, 14, 271???282,
- Eriksson, 1996, Diabetologia, 39, 573???579,
- Eriksson, 1991, Diabetologia, 34, 891???898,
- 1997, Diabetes Care, 20, 1183???1197,
- Greene, 1993, Diabetes Spectrum, 6, 234,
- Heath, 1983, J Appl Physiol, 57, 1857???1864,
- Hickey, 1995, Am J Physiol, 268, E453???E457,
- Holloszy, 1987, Acta Med Scand, 711, 55???65,
- Hubinger, 1987, Diabetes Res, 4, 57???61,
- Kahn, 1998, Cell, 92, 593???596,
- Kelley, 1984, J Psychosom Res, 28, 279???287,
- King, 1993, Diabetes Care, 16, 157???177,
- Koivisto, 1984, Acta Endocrinol, 262, 107???111,
- Leon, 1984, J Cardiopulm Rehabil, 4, 278???286,
- Lindg??rde, 1981, Diabetologia, 20, 134???138,
- McAuley, 1993, J Gerontol Psychol Sci, 48, 218???224,
- Miller, 1984, Med Sci Sports Exerc, 16, 539???543,
- Minuk, 1981, Am J Physiol, 240, E458???E464,
- 1987, Diabetes Care, 10, 639???644,
- Nyholm, 1996, Diabetoligia, 39, 813???822,
- Pan, 1997, Diabetes Care, 20, 537???544,
- Perry, 1995, Br Med J, 310, 560???564,
- Poehlman, 1992, Metabolism, 41, 1351???1360,
- Prochaska, 1994, Adv Med Sociol, 4, 141???161,
- Randle, 1963, Lancet, 21, 785???789,
- Reaven, 1994, Clinical Diabetes, 12, 32???36,
- Ronnemaa, 1988, Diabetes Res, 7, 79???84,
- R??nnemaa, 1986, Acta Med Scand, 220, 219???224,
- Ruderman, 1979, Diabetes, 28, 89???92,
- Ryan, 1996, J Gerontol A Biol Sci Med Sci, 51, M199???M205,
- Saltin, 1979, Diabetes, 28, 30???32,
- Santiago, 1986, Clin Chem, 32, B48???B53,
- Schneider, 1990, Diabetes Care, 17, 924???937,
- Shulman, 1990, N Engl J Med, 322, 223???228,
- Skinner, 1994, Am J Public Health, 84, 43???49,
- Stalonas, 1978, J Consult Clin Psychol, 46, 463???469,, 10.1037/0022-006x.46.3.463 · doi:10.1037/0022-006x.46.3.463
- Stern, 1991, Diabetes Care, 14, 399???410,
- Taylor, 1984, Diabetologia, 27, 578???582,
- Treuth, 1995, J Appl Physiol, 78, 1425???1431,
- Trovati, 1984, Diabetes Care, 7, 416???420,
- Van Gaal, 1988, Diabetes Care, 11, 103???106,
- Vranic, 1979, Diabetes, 28, 147???163,
- Yki-Jarvinen, 1992, Endocr Rev, 13, 415???431,
Cited by
Garber, C. E., Blissmer, B., Deschenes, M. R., Franklin, B. A., Lamonte, M. J., Lee, I.-M., Nieman, D. C., & Swain, D. P. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318213fefb · Cited by 9,319
Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases
Pedersen, B. K., & Saltin, B. (2015) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.12581 · Cited by 3,514
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., Chasan-Taber, L., Albright, A. L., & Braun, B. (2010) · Diabetes Care · doi:10.2337/dc10-9990 · Cited by 1,955
“Exercise should be begun at a low intensity and volume because aerobic capacity and muscle function are substantially reduced, and avoidance of the Valsava maneuver or high-intensity exercise to prevent excessive increases in BP is advised (1).”
InfluentialSelf-citationPescatello, L. S., Franklin, B. A., Fagard, R., Farquhar, W. B., Kelley, G. A., & Ray, C. A. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000115224.88514.3a · Cited by 1,872
Standards of Medical Care in Diabetes–2006
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s4 · Cited by 1,885
Metadata
- Authors
- Albright, A. J., FRANZ, M. M., Hornsby, W. G., Kriska, A. M., Marrero, D. G., Ullrich, I. H., & Verity, L.
- Venue
- Medicine & Science in Sports & Exercise
- Published
- 2000-07
- Volume
- 32
- Issue
- 7
- Pages
- 1345-1360
- ISSN
- 0195-9131 (ISSN-L)
- OpenAlex
- W2416937488
- Cited by
- 604
- References
- 122
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 8 · 2023: 5 · 2022: 16 · 2021: 14 · 2020: 9 · 2019: 15 · 2018: 29 · 2017: 22 · 2016: 25 · 2015: 27 · 2014: 31 · 2013: 24 · 2012: 36
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medicine & Science in Sports & Exercise (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, exercise therapy, physical activity, resistance training, endurance training, insulin sensitivity, glucose tolerance, autonomic neuropathy, peripheral neuropathy, exercise intensity, rating of perceived exertion, stages of change, exercise motivation, walking, cardiovascular risk factors, body composition, diabetes complications, exercise prescription, exercise adherence
- MeSH terms
- Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Hypoglycemia, Insulin Resistance, Oxygen Consumption, Physical Fitness, Risk Factors, Weight Loss, Exercise, Walking, Weight-Bearing, Peripheral Vascular Diseases, Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exercise and Type 2 Diabetes. https://app.cochat.ai/papers/10.1097/00005768-200007000-00024
- The paper
- Albright, A. J., FRANZ, M. M., Hornsby, W. G., Kriska, A. M., Marrero, D. G., Ullrich, I. H., & Verity, L. (2000). Exercise and Type 2 Diabetes. Medicine & Science in Sports & Exercise. https://doi.org/10.1097/00005768-200007000-00024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.